Long-Acting Injectables, Hub-and-Spoke Strategy, and Fighting Opioid Use Disorder: Jeff Missling on Leading Frenelle Pharma episode artwork

EPISODE · Oct 28, 2025 · 16 MIN

Long-Acting Injectables, Hub-and-Spoke Strategy, and Fighting Opioid Use Disorder: Jeff Missling on Leading Frenelle Pharma

from Lightning Rx: Marketing Innovation in Health

What if the next breakthrough in drug delivery wasn’t a new molecule, but a revolutionary way to make medicines work longer and safer?In this episode of Lightning RX, host Colette Nataf, founder of Lightning GTM, sits down with Jeff Missling, CEO of Frenelle Pharma, to discuss how their innovative Pharos platform is transforming long-acting injectable drugs across human and animal health.Jeff shares how Frenelle Pharma is tackling unmet medical needs by engineering precision biodegradable microspheres that enable safer, more effective treatments. He walks us through their unique hub-and-spoke business model, deploying their platform technology across multiple therapeutic areas, from low back pain to opioid use disorder, and even companion animal health.The conversation explores the challenges and opportunities of developing long-acting injectable therapies, strategic partnerships in biotech, and the mission-driven approach to expanding access to addiction treatment.What You’ll Learn:How Frenelle Pharma’s Pharos technology enables precise, long-acting drug deliveryThe advantages of a hub-and-spoke business model in biotech innovationThe unique regulatory pathway and market opportunity in companion animal healthAddressing safety and adoption barriers for injectable opioid use disorder treatmentsBuilding strategic partnerships and investor relations in a competitive landscapeThe importance of leadership, communication, and patience in drug developmentHow technology can improve patient compliance, outcomes, and quality of life💡 Golden Nugget:“Better is always possible; it’s about finding the opportunities where improved delivery can change the patient experience.”Connect with Jeff Missling:LinkedIn: linkedin.com/in/jeff-missling-a410814Connect with the Show:LinkedInWebsiteSpotifyAmazon MusiciHeartSubscribe on Spotify, Apple Podcasts, or your favorite platform.If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!

NOW PLAYING

Long-Acting Injectables, Hub-and-Spoke Strategy, and Fighting Opioid Use Disorder: Jeff Missling on Leading Frenelle Pharma

0:00 16:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lightning Rx: Marketing Innovation in Health?

This episode is 16 minutes long.

When was this Lightning Rx: Marketing Innovation in Health episode published?

This episode was published on October 28, 2025.

What is this episode about?

What if the next breakthrough in drug delivery wasn’t a new molecule, but a revolutionary way to make medicines work longer and safer?In this episode of Lightning RX, host Colette Nataf, founder of Lightning GTM, sits down with Jeff Missling, CEO of...

Can I download this Lightning Rx: Marketing Innovation in Health episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!